BioTalk is a news hub brought to you by Bird & Bird's International Life Sciences & Healthcare Group. Read more about us >

Posts with tag Life Sciences

Sort by Latest
Illumina v MGI: Patents Court gives guidance on the skilled person, CGK, and insufficiency
In Illumina v Latvia MGI Tech (MGI) [2021] EWHC 57 (Pat), Birss J (as he then was) has handed down a 520 paragraph judgment providing some helpful practical guidance in respect of several issues that commonly arise in UK patent litigation, namely: The definition of the skilled person for obviousness in cases where it is not same as the skilled person to whom the patent is addressed; That common general knowledge can include things that do not work as well...
March 26, 2021
9 min read
Singapore Gets Vaccinated! Introduction of the Pandemic...
As part of a slew of measures to mitigate the effect...
March 25, 2021
6 min read
Introduction of the Narcotic Drugs Amendment (Medicinal...
On the 3rd February 2021, the Narcotic Drugs Amendment (Medicinal...
March 2, 2021
1 min read
Impact of Brexit on Artificial Intelligence in Hea...
AI developments in the UK The UK is starting...
February 5, 2021
5 min read
Indirect infringement in Spanish courts: a trend reversal and some teachings concerning infringement of second use medical claims
The specialised Section No. 15 of the Appeal Court of Barcelona has recently clarified what indirect...
January 22, 2021
4 min read
Chinese patent linkage system – the Chinese Supreme Court issues Draft Judicial Interpretations
The Chinese Supreme Court (“SPC”) released on 29 October 2020 the “Provisions on Several...
November 13, 2020
6 min read
Managing Scientific Collaboration Agreements within the French Healthtech Sector
Scientific Collaboration Agreements allow a public servant, most of the time a researcher, (who...
November 9, 2020
5 min read
Australian Courts apply “European Support” test to find key Wyeth’s Prevnar 13 patent invalid
In the recent decision in the Australian front of the Prevnar 13 patent litigation, Merck...
November 4, 2020
10 min read
AstraZeneca held liable for additional healthcare costs
In a judgment of 14 October 2020 the District Court The Hague ruled in a landslide decision that AstraZeneca...
October 15, 2020
10 min read
French Healthtech in the Covid crisis: when strategic issues lead to growth
The strategic challenges of the French Healthtech sector - health, innovation, sovereignty - are undeniably...
October 13, 2020
6 min read
Cookie consent
We use analytics cookies to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential to make our website work. You can accept or reject our analytic cookies (including the collection of associated data) and change your mind at any time. Find out more in our Cookie Notice.